multicenter study doxazosin treatment essential hypertension France study efficacy tolerance doxazosin patients mild moderate severe essential hypertension general practice Ninety-six adults mean age years part study placebo phase weeks dose-adjustment phase doxazosin weeks maintenance phase weeks Doxazosin final mean daily dose mg significant reduction blood pressure points measurement study mean change blood pressure end treatment mm Hg patients success failure therapeutic success efficacy-evaluable patients improvement severity category hypertension Treatment doxazosin reduction serum cholesterol levels changes statistical significance calculated probability coronary heart disease years Framingham equation chances baseline chances final visit Twenty-six patients side effects treatment prevalent vertigo headache patients dose doxazosin investigator assessments tolerance excellent good patients 